ArticleIndian journal of surgical oncology2025
Modified Swede Colposcopic Index Versus Swede Score in Colposcopic Screening for Premalignant and Malignant Lesions of the Cervix.
Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colposcopy is an important secondary screening method to triage women needing biopsy for the diagnosis of cervical cancer. Different scoring systems have been introduced for the standardization of colposcopic variables' grading. The main variables are acetowhite uptake, cervical vasculature, and extent of involvement. Iodine staining and lesion size have also been used in the Reid scoring system and Swede score respectively. This study compares the diagnostic performance of the Modified Swede Colposcopic Index (MSCI) and Swede score for premalignant and malignant lesions to histopathology. This study was carried out in 150 women visiting AIIMS Deoghar OPD in Jharkhand after obtaining ethical clearance. The women with a history of postcoital bleeding, postmenopausal bleeding, and persistent discharge per vagina with unhealthy looking cervix were screened. The women with positive reports of Pap smear screening were included in the study after informed consent. Pregnant women, women with frank growth on the cervix, and women diagnosed and treated for cervical cancer were excluded. Colposcopy-guided biopsy samples were obtained from them and sent for histopathology. The results were recorded and analyzed. The sensitivity, specificity, PPV, and NPV of MSCI threshold score 9 for CIN2 and higher lesions were 96.55%, 68.07%, 51.38%, and 98.26% with an AUC of 0.718 (0.639-0.788 95% CI). The sensitivity, specificity, PPV, and NPV were calculated as 74.14%, 65.66%, 43%, and 87.9% for threshold Swede score 5 with an AUC of 0.630 (0.547-0.707 95% CI). The difference between the two ROC curves was significant with a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.